Nevertheless, given the propensity of TNF-inhibitors to induce a wide variety of PNS disorders, assessment for prolonged F-waves should be evaluated in patients presenting with a potential ALS-plus syndrome in the context of TNF-inhibitor therapy. This evidence concerns the gene TNF and amyotrophic lateral sclerosis.